The South America Meningococcal Vaccines Market continues to demonstrate robust expansion as serogroup B vaccines, protein-based recombinant formulations, and novel carrier protein technologies address the unique epidemiological challenges of meningococcal disease across the continent. With serogroup B representing a significant proportion of cases in several South American countries and...